Arcus Biosciences (RCUS) Competitor Comparison
We are evaluating the key criteria listed to compare Arcus Biosciences (RCUS) against its competitors in the Biotechnology industry.
Market Capitalization
88 / 368Gross Profits
260 / 278Total Revenue
84 / 300EBITDA
303 / 337Free Cashflow
317 / 352Quick Ratio
204 / 357Earnings per Share
269 / 359Dividend yield
0 / 6Total Cash
34 / 358Performance 3 years
180 / 368Performance 5 years
75 / 368Performance 10 years
113 / 368Linearity 3 years
154 / 368Linearity 5 years
87 / 368Linearity 10 years
5 / 368Total Rank
154 / 368Dividend Rank
358 / 368Valuation Rank
183 / 368Piotroski Rank
148 / 368Muliplier Rank
276 / 368Market Capitalization - RCUS ranking 88 / 368
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.